Centogene data on novel genetic risk factor for parkinson's disease in the lancet neurology

Cambridge, mass. and rostock, germany and berlin, sept. 25, 2024 (globe newswire) -- centogene n.v., the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced data from the company's rostock international parkinson's disease (ropad), further supporting the association of a rab32 gene mutation with parkinson's disease (pd). the study, published in the lancet neurology , builds on research from emil k. gustavsson and colleagues, who previously identified the rab32 c.213c>g (p.ser71arg; dbsnp rs200251693) variant as a novel monogenic cause of pd.
CNTG Ratings Summary
CNTG Quant Ranking